Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

5.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
The Tumor Microenvironment02:17

The Tumor Microenvironment

8.0K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

9.0K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adipocyte-specific NIK depletion enhances energy metabolism and glucose tolerance in mice.

The FEBS journal·2026
Same author

Irisin ameliorates obesity and insulin resistance via adipose tissue IL-33 and regulatory T cells.

Nature metabolism·2026
Same author

Proteomic profiling of extracellular fluids to identify secreted proteins from muscle and fat tissues.

Methods in cell biology·2025
Same author

The Roles of EDA2R in Ageing and Disease.

Aging cell·2025
Same author

Transcriptional landscape of skeletal muscle in cancer patients.

Trends in molecular medicine·2025
Same author

A consensus guide to preclinical indirect calorimetry experiments.

Nature metabolism·2025

Related Experiment Video

Updated: Mar 3, 2026

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
08:55

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

17.3K

CACHEXIA & BROWN FAT: A BURNING ISSUE IN CANCER.

Serkan Kir1, Bruce M Spiegelman1

  • 1Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.

Trends in Cancer
|May 2, 2017
PubMed
Summary

Cancer cachexia causes significant weight loss and impacts treatment outcomes. Tumor-derived parathyroid hormone-related protein (PTHrP) is implicated in fat wasting and muscle atrophy, presenting a potential therapeutic target.

Keywords:
Cancer cachexiaadipose tissuebrowningskeletal muscle atrophythermogenesis

More Related Videos

Cerenkov Luminescence Imaging of Interscapular Brown Adipose Tissue
06:28

Cerenkov Luminescence Imaging of Interscapular Brown Adipose Tissue

Published on: October 7, 2014

13.8K
Visualization and Quantification of Brown and Beige Adipose Tissues in Mice using [18F]FDG Micro-PET/MR Imaging
08:31

Visualization and Quantification of Brown and Beige Adipose Tissues in Mice using [18F]FDG Micro-PET/MR Imaging

Published on: July 1, 2021

3.6K

Related Experiment Videos

Last Updated: Mar 3, 2026

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
08:55

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

17.3K
Cerenkov Luminescence Imaging of Interscapular Brown Adipose Tissue
06:28

Cerenkov Luminescence Imaging of Interscapular Brown Adipose Tissue

Published on: October 7, 2014

13.8K
Visualization and Quantification of Brown and Beige Adipose Tissues in Mice using [18F]FDG Micro-PET/MR Imaging
08:31

Visualization and Quantification of Brown and Beige Adipose Tissues in Mice using [18F]FDG Micro-PET/MR Imaging

Published on: July 1, 2021

3.6K

Area of Science:

  • Oncology
  • Metabolic Disorders
  • Molecular Biology

Background:

  • Cachexia is a complex metabolic syndrome characterized by progressive weight loss in cancer patients.
  • It is associated with tumor-induced energy wasting, impacting treatment efficacy and patient quality of life.
  • Adipose tissue thermogenesis and its link to muscle atrophy are implicated in cachexia pathogenesis.

Purpose of the Study:

  • To investigate the role of tumor-derived parathyroid hormone-related protein (PTHrP) in cancer cachexia.
  • To explore PTHrP's function as a fat "browning" factor.
  • To identify PTHrP as a potential therapeutic target for cachexia.

Main Methods:

  • Analysis of tumor-derived factors in cachexia models.
  • Investigation of adipose tissue thermogenesis and browning.
  • Assessment of PTHrP signaling pathways in fat and muscle tissues.

Main Results:

  • Tumor-derived PTHrP plays a significant role in energy wasting associated with cachexia.
  • PTHrP acts as a mediator of adipose tissue "browning" and contributes to fat atrophy.
  • Evidence suggests a link between PTHrP-mediated fat atrophy and muscle wasting.

Conclusions:

  • Tumor-derived PTHrP is a key molecular player in cancer cachexia.
  • Targeting PTHrP may offer a novel therapeutic strategy to combat cachexia-induced wasting.
  • Further research into PTHrP's mechanisms could lead to improved patient outcomes.